日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tumor mutations predict HER2-targeted therapy resistance in primary HER2-positive breast cancer

肿瘤突变可预测原发性HER2阳性乳腺癌对HER2靶向治疗的耐药性

Van Mackelenbergh, Marion T; Pfarr, Nicole; Weber, Karsten; Untch, Michael; Solbach, Christine; Schneeweiss, Andreas; Jank, Paul; Blohmer, Jens; Treue, Denise; Schmatloch, Sabine; Lehmann, Annika; Hanusch, Claus; Link, Theresa; Sers, Christine; Bjelic-Radisic, Vesna; Hummel, Michael; Huober, Jens; Schmitt, Wolfgang D; Fasching, Peter A; Aktas, Bahriye; Rhiem, Kerstin; Reinisch, Mattea; Nekljudova, Valentina; Denkert, Carsten; Loibl, Sibylle

Hospital readmission in children on maintenance dialysis: a multicentre, prospective cohort study

维持性透析患儿的再入院情况:一项多中心前瞻性队列研究

Özdemir Atikel, Yeşim; Lévai, Eszter; Schmitt, Claus Peter; Adalat, Shazia; Goodman, Nadine; Pınarbaşı, Ayşe Seda; Dursun, İsmail; Yazıcıoğlu, Burcu; Paglialonga, Fabio; Vondrak, Karel; Guzzo, Isabella; Printza, Nikoleta; Zagożdżon, Ilona; Zurowska, Aleksandra; Atmış, Bahriye; Bayazıt, Aysun Karabay; Tkaczyk, Marcin; Faria, Maria do Sameiro; Zaloszyc, Ariane; Jankauskiene, Augustina; Ekim, Mesiha; Edefonti, Alberto; Shroff, Rukshana; Bakkaloğlu, Sevcan A

Clinical Significance of MTHFR C677T and A1298C Polymorphisms in Adult Patients with ALL and NHL

MTHFR C677T 和 A1298C 多态性在成人急性淋巴细胞白血病 (ALL) 和非霍奇金淋巴瘤 (NHL) 患者中的临床意义

Kiper Unal, Hatice Demet; Cetintepe, Tugba; Gasimli, Roya; Garip Acar, Alev; Aygun, Kemal; Solmaz, Serife; Subasioglu, Asli; Aksun, Saliha; Payzin, Bahriye

Case report: a rare BRCA1 de novo variant in a female with breast cancer

病例报告:一名患有乳腺癌的女性携带罕见的BRCA1新生突变

Dencker, Carlotta; Strehlow, Vincent; Aktas, Bahriye; Lemke, Johannes; Hentschel, Julia

Refining Risk Assessment for Adjuvant CDK4/6 Inhibitors beyond Trial Inclusion Criteria: Integrating Recurrence Score and Endocrine Responsiveness according to ADAPT

完善辅助性 CDK4/6 抑制剂的风险评估,超越临床试验纳入标准:根据 ADAPT 整合复发评分和内分泌反应性

Braun, Michael; Gluz, Oleg; Kuemmel, Sherko; Nitz, Ulrike; Luedtke-Heckenkamp, Kerstin; Darsow, Maren; Forstbauer, Helmut; Polata, Silke; Grischke, Eva-Maria; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Zu Eulenburg, Christine; Kates, Ronald; Burmeister, Sandy; Graeser, Monika; Wuerstlein, Rachel; Baehner, Rick; Christgen, Matthias; Kreipe, Hans Heinrich; Harbeck, Nadia

CBC ratios for early sepsis risk stratification in newborns: EOS/LOS versus non-septic controls

新生儿早期败血症风险分层中血细胞计数比值:早发型/晚发型败血症与非败血症对照组

Adıgüzel, Taner; Atasoy, Bahriye Semizoğlu; İşcan, Tuba; Kaya, Gülsüm

Immunomodulatory gene networks predict treatment response and survival to de-escalated, anthracycline-free neoadjuvant chemotherapy in triple-negative breast cancer in the WSG-ADAPT-TN trial

在WSG-ADAPT-TN试验中,免疫调节基因网络可预测三阴性乳腺癌患者对降阶梯、不含蒽环类药物的新辅助化疗的治疗反应和生存期。

Korbie, Darren; Stirzaker, Clare; Gluz, Oleg; Zu Eulenburg, Christine; Nitz, Ulrike; Christgen, Matthias; Kuemmel, Sherko; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Wuerstlein, Rachel; Pelz, Enrico; Kreipe, Hans Heinrich; Clark, Susan J; Trau, Matt; Graeser, Monika; Harbeck, Nadia

Real-world utilization of aromatase inhibitors, tamoxifen, and ovarian function suppression in premenopausal patients with early hormone receptor-positive, HER2-negative breast cancer with increased recurrence risk

在复发风险增加的绝经前早期激素受体阳性、HER2阴性乳腺癌患者中,芳香化酶抑制剂、他莫昔芬和卵巢功能抑制的实际应用情况

Müller, Volkmar; Hörner, Manuel; Thill, Marc; Banys-Paluchowski, Maggie; Schmatloch, Sabine; Fasching, Peter A; Harbeck, Nadia; Langanke, Dagmar; Uhrig, Sabrina; Häberle, Lothar; Fischer, Dorothea; Hein, Alexander; Fehm, Tanja N; Goossens, Chloë; Terhaag, Jürgen; Heilenkötter, Uwe; Dall, Peter; Rudlowski, Christian; Wuerstlein, Rachel; Aydogdu, Mustafa; Keyver-Paik, Mignon-Denise; Hammerle, Carolin; Deuerling, Natalija; Stickeler, Elmar; Aktas, Bahriye; Belleville, Erik; Thoma, Martin; Ditsch, Nina; Baila, Yasmin; Roos, Christian; Mann, Christian; Iuliano, Caterina; Brucker, Sara Y; Schneeweiss, Andreas; Hartkopf, Andreas D

HER2-low status as a distinct breast cancer subtype: myth or truth? Analysis of the WSG trials WSG-ADAPT-HR+/HER2-, WSG-PlanB, and WSG-ADAPT-TN

HER2低表达状态作为一种独特的乳腺癌亚型:是谬论还是事实?对WSG试验WSG-ADAPT-HR+/HER2-、WSG-PlanB和WSG-ADAPT-TN的分析

Schmidt, Gilda; Gluz, Oleg; Christgen, Matthias; Reinisch, Mattea; Kümmel, Sherko; Nitz, Ulrike; Braun, Michael; Aktas, Bahriye; Lüdtke-Heckenkamp, Kerstin; Forstbauer, Helmut; Grischke, Eva-Maria; Schumacher, Claudia; Mahlberg, Rolf; Malter, Wolfram; Reimer, Toralf; Nuding, Benno; Stefek, Andrea; Wuerstlein, Rachel; Graeser, Monika; Jóźwiak, Katarzyna; Burmeister, Sandy; Zu Eulenburg, Christine; Lauseker, Michael; Kolberg-Liedtke, Cornelia; Prat, Aleix; Schmid, Peter; Baehner, Rick; Kreipe, Hans Heinrich; Solomayer, Erich-Franz; Harbeck, Nadia

Characterization of Disseminated Tumor Cells (DTCs) in Patients with Triple-Negative Breast Cancer (TNBC).

三阴性乳腺癌 (TNBC) 患者播散性肿瘤细胞 (DTC) 的特征分析

Eckardt Anne, Nel Ivonne, Weydandt Laura, Brochwitz Elisa, Höhn Anne Kathrin, Winter Karsten, Aktas Bahriye